Free Trial

Benitec Biopharma (BNTC) Institutional Ownership

Benitec Biopharma logo
$12.77 +0.19 (+1.51%)
(As of 12/17/2024 ET)

Institutional Ownership Changes (13F Filings) for Benitec Biopharma (NASDAQ:BNTC)

Current
Institutional Ownership
Percentage
52.19%
Number of
Institutional Buyers
(last 12 months)
7
Total
Institutional Inflows
(last 12 months)
$73.25M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$223.25K
Get BNTC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Benitec Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

BNTC Institutional Buying and Selling by Quarter

Benitec Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024 Geode Capital Management LLC83,987$772K0.0%+31.3%0.795%
11/15/2024 Janus Henderson Group PLC876,523$8.03M0.0%-2.7%8.300%
11/14/2024 Suvretta Capital Management LLC8,829,053$81.14M2.6%+422.0%83.640%
11/14/2024 Acuta Capital Partners LLC29,800$274K0.2%N/A0.282%
11/6/2024 Simplify Asset Management Inc.116,535$1.07M0.0%+127.5%1.104%
10/7/2024 GAMMA Investing LLC6,540$60K0.0%+20.3%0.070%
8/20/2024 Nantahala Capital Management LLC841,395$5.88M0.3%N/A8.982%
8/13/2024 Simplify Asset Management Inc.51,216$358K0.0%N/A0.547%
7/2/2024 GAMMA Investing LLC5,438$38K0.0%+53.0%0.058%
5/16/2024 Janus Henderson Group PLC244,491$1.27M0.0%+35.5%9.440%
11/15/2023 Adage Capital Partners GP L.L.C.189,188$572K0.0%N/A7.419%
11/15/2022Empery Asset Management LP796,837$296K1.8%N/A2.848%
11/15/2022 Cantor Fitzgerald L. P.133,805$50K0.0%N/A0.478%
11/14/2022 Armistice Capital LLC1,555,039$578K0.0%N/A6.025%
11/14/2022 Altium Capital Management LP658,796$245K0.1%N/A2.552%
11/9/2021BlackRock Inc.19,974$71K0.0%-16.4%0.244%
8/16/2021 State Street Corp21,000$89K0.0%N/A0.267%
8/13/2021 Renaissance Technologies LLC42,700$181K0.0%N/A0.544%
8/13/2021 Northern Trust Corp11,813$50K0.0%N/A0.150%
8/13/2021 Geode Capital Management LLC34,493$146K0.0%+20.8%0.439%
8/13/2021 Vanguard Group Inc.74,773$318K0.0%+43.3%0.952%
8/11/2021 Bank of New York Mellon Corp14,932$63K0.0%-15.4%0.190%
7/31/2021 Private Wealth Advisors LLC15,043$64K0.0%N/A0.192%
5/21/2021 Citadel Advisors LLC23,253$120K0.0%N/A0.483%
5/19/2021 Virtu Financial LLC22,520$116K0.0%+17.8%0.467%
5/18/2021 Citadel Advisors LLC23,253$120K0.0%N/A0.483%
5/13/2021 Bank of New York Mellon Corp17,653$91K0.0%N/A0.366%
5/12/2021 Geode Capital Management LLC28,560$147K0.0%N/A0.593%
4/14/2021 WealthTrust Axiom LLC12,950$66K0.0%N/A0.269%
4/12/2021 HighPoint Advisor Group LLC93,000$462K0.1%N/A1.930%
3/4/2021 Hudson Bay Capital Management LP107,995$324K0.0%N/A2.241%
2/24/2021 Virtu Financial LLC19,114$57K0.0%N/A0.397%
2/16/2021 Warberg Asset Management LLC10,000$30K0.0%N/A0.903%
2/10/2021 Renaissance Technologies LLC50,660$152K0.0%N/A4.572%
11/13/2020 Morgan Stanley34,838$219K0.0%+18.7%3.144%
(Data available from 1/1/2016 forward)

BNTC Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BNTC shares?

During the previous two years, the following institutional investors and hedge funds held shares of Benitec Biopharma shares: Suvretta Capital Management LLC ($81.14M), Janus Henderson Group PLC ($8.03M), Nantahala Capital Management LLC ($5.88M), Simplify Asset Management Inc. ($1.07M), Geode Capital Management LLC ($772K), Adage Capital Partners GP L.L.C. ($572K), and Acuta Capital Partners LLC ($274K).Learn more on BNTC's institutional investors.

What percentage of Benitec Biopharma stock is owned by institutional investors?

52.19% of Benitec Biopharma stock is owned by institutional investors. Learn more on BNTC's institutional investor holdings.

Which institutional investors have been buying Benitec Biopharma stock?

The following institutional investors have purchased Benitec Biopharma stock in the last 24 months: Suvretta Capital Management LLC ($7.14M), Nantahala Capital Management LLC ($841.40K), Adage Capital Partners GP L.L.C. ($189.19K), Simplify Asset Management Inc. ($116.54K), Janus Henderson Group PLC ($64.09K), Acuta Capital Partners LLC ($29.80K), and Geode Capital Management LLC ($20.01K).

How much institutional buying is happening at Benitec Biopharma?

Institutional investors have bought a total of 8,401,771 shares in the last 24 months. This purchase volume represents approximately $73.82M in transactions.

Which Benitec Biopharma major shareholders have been selling company stock?

The following institutional investors have sold Benitec Biopharma stock in the last 24 months: Janus Henderson Group PLC ($24.29K).

How much institutional selling is happening at Benitec Biopharma?

Institutional investors have sold a total of 24,293 shares in the last 24 months. This volume of shares sold represents approximately $223.25K in transactions.



This page (NASDAQ:BNTC) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners